Understanding ADHD | About ADHD | ADHD in the News | Weekly ADHD News
The National Resource Center

ADHD in the News 01-18-18

Few US Children with ADHD Receive Recommended Psychosocial Treatment (MD Magazine, January 15, 2018)

"Analysis of data from the largest nationally drawn sample of children with attention-deficit/hyperactivity disorder (ADHD) collected in the past 2 decades revealed medication and school supports are more commonly provided than psychosocial treatments, and that rates of treatments vary between some demographic groups. (MD Magazine, January 15, 2018)..." Full Story

 

ACCESS Therapy Shows Promise for College Students with ADHD (MD Magazine, January 17, 2018)

"An open clinical trial published in the Journal for Attention Disorders this month highlights the efficacy of cognitive behavioral interventions in helping high school students with attention deficit/hyperactivity disorder (ADHD) successfully transition to college. (MD Magazine, January 17, 2018)..." Full Story

 

CBT for Adult ADHD: Getting Patients to Do What They Know They Need to Do (AJMC.com, January 15, 2018)

"Psychologist J. Russell Ramsay, PhD, presented at the 2018 annual meeting of the American Professional Society of ADHD and Related Disorders about his model for understanding and treating adult attention-deficit/hyperactivity disorder (ADHD) with cognitive-behavioral therapy (CBT) in his session, "Intentions into Actions: CBT for Adult ADHD." (AJMC.com, January 15, 2018)..." Full Story

 

New Ways of Thinking About ADHD and Cognition at 2018 APSARD Annual Meeting (AJMC.com, January 14, 2018)

"During the welcome and opening plenary session of the annual meeting of the American Professional Society of ADHD and Related Disorders (APSARD), 3 speakers gave an overview of different models of cognitive and neural processes that underlie the symptoms, impairments, and medication treatment models of attention-deficit/hyperactivity disorder (ADHD). (AJMC.com, January 14, 2018)..." Full Story

 

Rarity of Late-Onset ADHD: Symptoms Linked to Other Causes (Psychiatry Advisor, January 17, 2018)

"According to a study published in the American Journal of Psychiatry, approximately 95% of adolescents and young adults who screened positive for late-onset attention-deficit/hyperactivity disorder (ADHD) based on symptom checklists were later excluded from late-onset ADHD diagnosis based on the identification of other causes of symptoms. (Psychiatry Advisor, January 17, 2018)..." Full Story

 

Formulation-Based CBT Improves Symptoms, Functioning in Adults With ADHD (Psychiatry Advisor, January 11, 2018)

"Individual formulation-based cognitive behavioral therapy (CBT) with usual treatment is more effective than usual treatment alone for improving core symptoms, functioning, and emotional distress in adults with attention-deficit/hyperactivity disorder (ADHD), according to data published in Acta Psychiatrica Scandinavica. (Psychiatry Advisor, January 11, 2018)..." Full Story

 

Medicaid Prior Authorization Policies Impact ADHD Treatments (MD Magazine, January 17, 2018)

"An examination of Medicaid prior authorization policies for medication treatment of attention-deficit/hyperactivity disorder (ADHD) finds policies are inconsistent across states, which could influence whether treatments are consistent with, or differ from recommended practices. (MD Magazine, January 17, 2018)..." Full Story

 

Psychologist Barkley Says Life Expectancy Slashed in Worst Cases for Those With ADHD (AJMC.com, January 14, 2018)

"Using a large database created by a center for actuarial studies, a psychologist and researcher is positing that people with the worst cases of attention-deficit/hyperactivity disorder (ADHD) will see a 25-year reduction in life expectancy, according to a presentation made Saturday at the annual meeting of the American Professional Society of ADHD and Related Disorders. (AJMC.com, January 14, 2018)..." Full Story

 

Methylphenidate Formulation Modeled to Maximize Benefit in ADHD (MD Magazine, January 15, 2018)

"A proposed novel modeling of an oral methylphenidate formulation for attention-deficit/hyperactivity disorder (ADHD) goes beyond the traditional relating of in-vitro dissolution and drug release with in-vivo serum drug levels, to specify the amount and time of drug release which can best evoke clinical benefit. (MD Magazine, January 15, 2018)..." Full Story

 

     


Connect with others
Talk to Specialist
Sign up for ADHD Newsletter
NRC Library
Ask the Expert Webcasts
The information provided on this website was supported by Cooperative Agreement Number NU38DD005376 funded by the Centers for Disease Control and Prevention (CDC). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the CDC or the Department of Health and Human Services.

Terms of Use